The Intrauterine Device and the Intrauterine System
Overview
Authors
Affiliations
Intrauterine contraception is used by about 100 million women worldwide, making it the most popular form of fertility regulation. In UK community contraception clinics, however, long-acting reversible contraception has increased to 28% of users, and intrauterine contraception accounts for only 8% of methods used by women accessing these services. Potential exists to increase uptake of these more effective methods. In this chapter, we review the clinical advantages, disadvantages and cost-effectiveness of intrauterine contraception. We discuss the management of complications along with advice for trainers, and briefly consider issues in developing countries.
Anwaar A, Karamat R, Khanzada M, Akilimali A, Aamir M, Arshad M Clin Case Rep. 2025; 13(1):e70061.
PMID: 39776775 PMC: 11705494. DOI: 10.1002/ccr3.70061.
Migrated intra-uterine device to infra-umbilical skin: a rare case report.
Addis N, Sibhat Y, Molla Y, Mengestu W, Seid A, Damite M BMC Womens Health. 2024; 24(1):672.
PMID: 39736668 PMC: 11684260. DOI: 10.1186/s12905-024-03522-0.
Gebremichael A, Teka H, Abadi K, Siferih M, Moges M, Arusi M Int Med Case Rep J. 2024; 17:71-76.
PMID: 38293615 PMC: 10826545. DOI: 10.2147/IMCRJ.S441386.
Varan C, Aksut D, Sen M, Bilensoy E Pharmaceutics. 2023; 15(4).
PMID: 37111639 PMC: 10146591. DOI: 10.3390/pharmaceutics15041154.
Intrauterine device found in an ovarian tumor: A case report.
An Y, Liu C, Mao F, Yang G, Mao G Medicine (Baltimore). 2020; 99(42):e22825.
PMID: 33080762 PMC: 7571936. DOI: 10.1097/MD.0000000000022825.